Cervical Cancer Complementary/Integrative Therapies-

Share Button

Cervical Cancer Patients Must Think Outside the Box to Reach Long Term Remission while Minimizing Collateral Damage aka Side Effects

A cancer diagnosis is one of the most difficult life experiences you will ever face. The world of cancer therapy is confusing at best, frustrating at worst. Though it may be difficult to see beyond what your oncologist calls your “induction therapy” (initial therapy), I strongly encourage you to look at the bigger picture.

I am a long-term cancer survivor and cancer coach. I have remained in complete remission from my incurable cancer since 1999 by living an evidence-based, non-toxic, anti-cancer lifestyle through nutrition, supplementation, bone health, lifestyle and mind-body therapies.

Image result for photo of strong woman

By bigger picture I mean that you must look at both killing your cancer as well as minimizing side effects that can damage your body in the short, long-term and perhaps late stages.

The studies linked and excerpted below talk about cervical cancer therapies that can both enhance conventional chemotherapy while minimizing toxicity. If you can get an honest opinion from your oncologist, he/she will tell you than a single agent such as cisplatin is both toxic and limited in its efficacy. Utilizing evidence-based therapies to attack your cancer is smart. Especially if the therapies are relatively inexpensive and have few if any side effects of their own.

Do you have cervical cancer? Are you living with short, long-term and late stage side effects?

For more information about other non-toxic, evidence-based therapies to support your cancer management efforts, scroll down the page, post a question or comment and I will reply ASAP.

Thank you,

David Emerson

  • Long-term cancer survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

TQ shows synergistic and/or potentiating anticancer effects when combined with clinically used chemotherapeutic agents...”

Curcumin, cervical and ovarian cancers-

Curcumin supplementation has shown anti-cancer action in breast, prostate, pancreatic, multiple myeloma and other cancers. The studies below cite the ability of curcumin to both kill both ovarian and cervical cancer cells while enhancing the efficacy of certain chemotherapies….”

Apoptotic activities of thymoquinone, an active ingredient of black seed (Nigella sativa), in cervical cancer cell lines.

“Thymoquinone (TQ) is the main constituent of black seed (Nigella sativa, spp) essential oil which shows promising in vitro and in vivo anti-neoplastic activities in different tumor cell lines.

However, to date there are only a few reports regarding the apoptotic effects of TQ on cervical cancer cells. Here, we report that TQ stimulated distinct apoptotic pathways in two human cervical cell lines, Siha and C33A. TQ markedly induced apoptosis as demonstrated by cell cycle analysis in both cell lines.

Moreover, quantitative PCR revealed that TQ induced apoptosis in Siha cells through p53-dependent pathway as shown by elevated level of p53-mediated apoptosis target genes, whereas apoptosis in C33A cells was mainly associated with the activation of caspase-3…

These results support previous findings on TQ as a potential therapeutic agent for human cervical cancer.”

Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.

Thymoquinone (TQ), the active constituent of Nigella sativa or black cumin exhibited cytotoxic effects in several cancer cell lines. In this study, the cytotoxicity of TQ in human cervical squamous carcinoma cells (SiHa) was investigated. TQ was cytotoxic towards SiHa cells…

TQ was more cytotoxic towards SiHa cells compared to cisplatin. Interestingly, TQ was less cytotoxic towards the normal cells (3T3-L1 and Vero)...In conclusion, thymoquinone from N. sativa was more potent than cisplatin in elimination of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.

Leave a Comment:

2 comments
Add Your Reply